Commissariat A L'energie Atomique Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01377220
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Commissariat A L'energie Atomique | Commissariat à l'Energie Atomique